ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
58,071.75
-0.29%
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs Yen
155.8085
0.06%
Brent Oil
83.625
0.10%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Immunovant Inc (IMVT)

  7. Immunovant Inc (IMVT) ニュース

IMVT Immunovant Inc

28.52
1.08 (3.94%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Immunovant Inc IMVT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
1.08 3.94% 28.52 07:04:45
始値 安値 高値 終値 前日終値
27.31 27.30 29.26 28.52 27.44
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/1220:30GLOBEImmunovant Awarded U.S. Patent for IMVT-1402
2024/2/2406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1422:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1221:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1221:02EDGAR2Form 8-K - Current report
2024/1/3006:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2006:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1621:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/1306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0922:08EDGAR2Form 8-K - Current report
2024/1/0322:00GLOBEImmunovant to Present at the 42nd Annual J.P. Morgan..
2023/12/2107:40DJNImmunovant Gets Positive Data From Graves' Disease Treatment..
2023/12/2106:37EDGAR2Form 8-K - Current report
2023/12/2106:30GLOBEImmunovant Reports Positive Initial Phase 2 Results for..
2023/11/2821:43EDGAR2Form 8-K - Current report
2023/11/2821:00GLOBEImmunovant Announces Positive IMVT-1402 Initial 600 mg MAD..
2023/11/2504:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2504:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2504:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2504:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1322:00GLOBEImmunovant to Present at Upcoming Investor Conferences
2023/11/0922:49EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/0921:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:06EDGAR2Form 8-K - Current report
2023/11/0921:00GLOBEImmunovant Reports Financial Results and Provides Corporate..
2023/10/2105:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1205:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0706:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0706:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0305:52GLOBEImmunovant Announces Closing of Upsized Common Stock..
2023/9/3005:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/2906:23EDGAR2Form 8-K - Current report
2023/9/2819:09EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2023/9/2812:41GLOBEImmunovant Announces Pricing of $450 Million Common Stock..
2023/9/2706:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/2706:00GLOBEImmunovant Announces Proposed Offering of $300 Million of..
2023/9/2620:45EDGAR2Form 8-K - Current report
2023/9/2619:00GLOBEImmunovant Announces Positive Initial IMVT-1402 Phase 1 SAD..
2023/9/2612:01GLOBEImmunovant to Host Conference Call and Webcast to Report..
2023/9/0205:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2606:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2606:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2605:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2405:48EDGAR2Form 8-K - Current report
2023/8/1705:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1020:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

最近閲覧した銘柄

NASDAQ
IMVT
Immunovant
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有